Three Rivers has Closed $0.65 million in Financing
TORONTO, ON, April 29, 2016 - Three Rivers Cardiovascular Systems, a company specializing in the development and commercialization of multi-sensor medical devices for interventional cardiology, has closed a total of $0.65 million in financing.
The company’s founders and individual investors (interventional cardiologists, physicians and angel investors) has invested a total of $500,000 in seed capital (equity and convertible notes) for the development of novel medical devices.
“With interventional cardiologists and physicians leading seed capital investments, it clearly shows Three Rivers’ game-changing solutions for interventional cardiology,” says Eric Caron, CEO of Three Rivers Cardiovascular Systems.
Along with these investments, Three Rivers secured a total of $150,000 in non-dilutive grants from the government of Canada, furthering its relevance as a company developing breakthrough medical technologies that enable accurate patient diagnoses and health monitoring.
About Three Rivers:
The company was founded in 2013 to develop and commercialize multi-sensor medical devices for interventional cardiologists. Three Rivers’ innovative medical devices provide real-time critical data for heart diagnosis and therapy to improve patient outcomes while reducing healthcare costs with heart diseases.